HR 4332 · 112th Congress 2011โ€“2013, ended

Generic Drug Application Review Fairness Act of 2012

Latest action · Mar 30, 2012 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMar 29, 2012
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Generic Drug Application Review Fairness Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act to extend from 30 to 60 months after application the period for a first applicant of a generic drug to obtain tentative approval without forfeiting the 180-day exclusivity period with respect to such drug, unless the failure in meeting the extended period is caused by a change in or review of approval requirements. Limits extension coverage to applications filed within 30 months preceding the enactment of this Act.

Reduces such extended period by six months per year over a five-year period, beginning on October 1, 2013.

Directs the Secretary of Health and Human Services (HHS) to maintain the Office of Generic Drugs as a separate office within the Center for Drug Evaluation and Research of the Food and Drug Administration (FDA).

Cosponsors 6

Members who signed on, in the order they did. Signatures ran from Mar 29, 2012 to May 9, 2012; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
R-KYBrett GuthrieOriginalMar 29, 2012
D-UTJim MathesonApr 18, 2012
R-TXMichael C. BurgessApr 24, 2012
D-MIJohn D. DingellApr 25, 2012
D-CODiana DeGetteMay 9, 2012
R-ILRobert J. DoldMay 9, 2012

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Mar 29, 2012
Health Subcommittee
Referred Mar 30, 2012

Actions 3

Everything that happened, newest first.

  1. Mar 30, 2012Referred to the Subcommittee on Health.
  2. Mar 29, 2012Introduced in House
  3. Mar 29, 2012Referred to the House Committee on Energy and Commerce.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I, Section 8, Clause 3 The Congress shall have power to regulate Commerce with foreign Nations, and among the several States, and with the Indian Tribes.

The sponsor’s statement, as printed in the page H1806.

Printed hearings 1

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
Serial No. 112-136FDA USER FEES 2012: HOW INNOVATION HELPS PATIENTS AND JOBS211 pagesEnergy and Commerce CommitteeApr 18, 2012

Related bills 1

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
HR 5651Food and Drug Administration Reform Act of 2012Related billJun 4, 2012

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend section 505(j) of the Federal Food, Drug, and Cosmetic Act to extend the period for a first applicant, with respect to a generic drug, to obtain tentative approval without forfeiting the 180-day exclusivity period, and for other purposes.
Short Titles as Introduced
Generic Drug Application Review Fairness Act of 2012

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Mar 29, 2012Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.